{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:50:47Z","timestamp":1762660247393,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T00:00:00Z","timestamp":1650931200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anais Brasileiros de Dermatologia"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.abd.2021.09.009","type":"journal-article","created":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T18:15:14Z","timestamp":1653934514000},"page":"448-457","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Icatibant use in Brazilian patients with hereditary angioedema (HAE) type 1 or 2 and HAE with normal C1-INH levels: findings from the Icatibant Outcome Survey Registry Study"],"prefix":"10.1016","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9803-0309","authenticated-orcid":false,"given":"Anete S.","family":"Grumach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6028-9307","authenticated-orcid":false,"given":"Marina T.","family":"Henriques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9831-4080","authenticated-orcid":false,"given":"Maine L.D.","family":"Bardou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6661-5337","authenticated-orcid":false,"given":"Daniele A.","family":"Pontarolli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaco","family":"Botha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4856-7578","authenticated-orcid":false,"given":"Mariangela","family":"Correa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.abd.2021.09.009_bib0005","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.iac.2017.04.007","article-title":"The clinical evaluation of angioedema","volume":"37","author":"Gill","year":"2017","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.abd.2021.09.009_bib0010","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jaci.2012.05.055","article-title":"Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency","volume":"130","author":"Bork","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.abd.2021.09.009_bib0015","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.anai.2018.07.025","article-title":"Long-term prophylaxis therapy in patients with hereditary angioedema with C1 inhibitor deficiency","volume":"121","author":"Craig","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.abd.2021.09.009_bib0020","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/1054773818780102","article-title":"The diagnosis of hereditary angioedema: family caregivers\u2019 experiences","volume":"29","author":"Granero-Molina","year":"2020","journal-title":"Clin Nurs Res"},{"key":"10.1016\/j.abd.2021.09.009_bib0025","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.anai.2013.08.019","article-title":"The burden of illness in patients with hereditary angioedema","volume":"111","author":"Banerji","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.abd.2021.09.009_bib0030","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.anai.2020.02.018","article-title":"Patient-reported burden of hereditary angioedema: findings from a patient survey in the United States","volume":"124","author":"Banerji","year":"2020","journal-title":"Ann Allergy Asthma Immunol."},{"key":"10.1016\/j.abd.2021.09.009_bib0035","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1111\/all.13384","article-title":"The international WAO\/EAACI guideline for the management of hereditary angioedema - the 2017 revision and update","volume":"73","author":"Maurer","year":"2018","journal-title":"Allergy."},{"key":"10.1016\/j.abd.2021.09.009_bib0040","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13223-019-0376-8","article-title":"The International\/Canadian Hereditary Angioedema Guideline","volume":"15","author":"Betschel","year":"2019","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.abd.2021.09.009_bib0045","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jaip.2019.10.003","article-title":"C1 inhibitor activity and angioedema attacks in patients with hereditary angioedema","volume":"8","author":"Kaplan","year":"2020","journal-title":"J Allergy Clin Immunol Pract."},{"key":"10.1016\/j.abd.2021.09.009_bib0050","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.tmrv.2019.08.002","article-title":"The role of complement in hereditary angioedema","volume":"33","author":"Levi","year":"2019","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.abd.2021.09.009_bib0055","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.jaip.2018.04.022","article-title":"Angioedema due to bradykinin dysregulation","volume":"6","author":"Cicardi","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.abd.2021.09.009_bib0060","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMra1808012","article-title":"Hereditary angioedema","volume":"382","author":"Busse","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.abd.2021.09.009_bib0065","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1111\/all.14454","article-title":"A myoferlin gain-of-function variant associates with a new type of hereditary angioedema","volume":"75","author":"Ariano","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.abd.2021.09.009_bib0070","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.gendis.2019.07.002","article-title":"An update on the genetics and pathogenesis of hereditary angioedema","volume":"7","author":"Banday","year":"2019","journal-title":"Genes Dis"},{"key":"10.1016\/j.abd.2021.09.009_bib0075","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/all.13270","article-title":"Hereditary angioedema with a mutation in the plasminogen gene","volume":"73","author":"Bork","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.abd.2021.09.009_bib0080","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jaip.2017.09.025","article-title":"Hereditary angioedema with normal C1 inhibitor and F12 mutations in 42 Brazilian families","volume":"6","author":"Veronez","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.abd.2021.09.009_bib0085","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13223-019-0381-y","article-title":"Review of the Manitoba cohort of patients with hereditary angioedema with normal C1 inhibitor","volume":"15","author":"McKibbin","year":"2019","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.abd.2021.09.009_bib0090","doi-asserted-by":"crossref","first-page":"e338","DOI":"10.1111\/j.1468-3083.2012.04670.x","article-title":"Hereditary angioedema: first report of the Brazilian registry and challenges","volume":"27","author":"Grumach","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.abd.2021.09.009_bib0095","unstructured":"ibge.gov [Internet]. Instituto Brasileiro de Geografia e Estat\u00edstica. Proje\u00e7\u00e3o da popula\u00e7\u00e3o do Brasil e das Unidades da Federa\u00e7\u00e3o; [cited 2020 Nov 23]. Available from: https:\/\/www.ibge.gov.br\/apps\/populacao\/projecao\/index.html."},{"key":"10.1016\/j.abd.2021.09.009_bib0100","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/j.1398-9995.2011.02658.x","article-title":"A single nucleotide deletion at the C1 inhibitor gene as the cause of hereditary angioedema: insights from a Brazilian family","volume":"66","author":"Ferraro","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.abd.2021.09.009_bib0105","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/all.13699","article-title":"Genotype-phenotype correlations in Brazilian patients with hereditary angioedema due to C1 inhibitor deficiency","volume":"74","author":"Maia","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.abd.2021.09.009_bib0110","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/ijd.14676","article-title":"Hereditary angioedema: a prospective study of a Brazilian single-center cohort","volume":"59","author":"Alonso","year":"2020","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.abd.2021.09.009_bib0115","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000376547","article-title":"Coagulation factor XII gene mutation in Brazilian families with hereditary angioedema with normal C1 inhibitor","volume":"166","author":"Moreno","year":"2015","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.abd.2021.09.009_bib0120","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1590\/abd1806-4841.20131818","article-title":"Hereditary angioedema type III (estrogen-dependent) report of three cases and literature review","volume":"88","author":"Miranda","year":"2013","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.abd.2021.09.009_bib0125","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/bjd.13791","article-title":"First report of a FXII gene mutation in a Brazilian family with hereditary angio-oedema with normal C1 inhibitor","volume":"173","author":"Stieber","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2021.09.009_bib0130","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2500\/aap.2019.40.4207","article-title":"Assessment on hereditary angioedema burden of illness in Brazil: a patient perspective","volume":"40","author":"Barbosa","year":"2019","journal-title":"Allergy Asthma Proc."},{"key":"10.1016\/j.abd.2021.09.009_bib0135","doi-asserted-by":"crossref","first-page":"81","DOI":"10.6061\/clinics\/2013(01)OA13","article-title":"Hereditary angioedema: quality of life in Brazilian patients","volume":"68","author":"Gomide","year":"2013","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.abd.2021.09.009_bib0140","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/ab8fe636-8b5b-420e-9cbf-1bef0a19b63f","article-title":"Hereditary angioedema attacks resolve faster and are shorter after early icatibant treatment","volume":"8","author":"Maurer","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.abd.2021.09.009_bib0145","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/iid3.137","article-title":"Hereditary angioedema with normal C1 inhibitor in a French cohort: clinical characteristics and response to treatment with icatibant","volume":"5","author":"Bouillet","year":"2017","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.abd.2021.09.009_bib0150","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1111\/all.13543","article-title":"Plasminogen gene mutation with normal C1 inhibitor hereditary angioedema: three additional French families","volume":"73","author":"Belb\u00e9zier","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.abd.2021.09.009_bib0155","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.iac.2017.04.004","article-title":"Hereditary angioedema with normal C1 inhibitor: update on evaluation and treatment","volume":"37","author":"Magerl","year":"2017","journal-title":"Immunol Allergy Clin North Am"},{"issue":"Suppl 1","key":"10.1016\/j.abd.2021.09.009_bib0160","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.2500\/aap.2012.33.3627","article-title":"Hereditary angioedema with normal C1 inhibitor function: consensus of an international expert panel","volume":"33","author":"Zuraw","year":"2012","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.abd.2021.09.009_bib0165","first-page":"59","article-title":"Long-term effectiveness and safety of icatibant for the on-demand treatment of hereditary angioedema attacks: 10 years of the Icatibant Outcome Survey. Abstract 1118","volume":"75","author":"Maurer","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.abd.2021.09.009_bib0170","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S1081-1206(10)60369-9","article-title":"Bradykinin receptor 2 antagonist (icatibant) for hereditary angioedema type III attacks","volume":"103","author":"Bouillet","year":"2009","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.abd.2021.09.009_bib0175","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/cei.12820","article-title":"Hereditary angioedema with normal C1 inhibitor and factor XII mutation: a series of 57 patients from the French National Center of Reference for Angioedema","volume":"185","author":"Deroux","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.abd.2021.09.009_bib0180","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1056\/NEJMoa0906393","article-title":"Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema","volume":"363","author":"Cicardi","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.abd.2021.09.009_bib0185","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.anai.2011.08.015","article-title":"Randomized placebo-controlled trial of the bradykinin B\u2082 receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial","volume":"107","author":"Lumry","year":"2011","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.abd.2021.09.009_bib0190","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2249.2012.04574.x","article-title":"Safety, and efficacy of icatibant self-administration for acute hereditary angioedema","volume":"168","author":"Boccon-Gibod","year":"2012","journal-title":"Clin Exp Immunol"}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059622000666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059622000666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T23:40:21Z","timestamp":1759794021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0365059622000666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0365059622000666"],"URL":"https:\/\/doi.org\/10.1016\/j.abd.2021.09.009","relation":{},"ISSN":["0365-0596"],"issn-type":[{"type":"print","value":"0365-0596"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Icatibant use in Brazilian patients with hereditary angioedema (HAE) type 1 or 2 and HAE with normal C1-INH levels: findings from the Icatibant Outcome Survey Registry Study","name":"articletitle","label":"Article Title"},{"value":"Anais Brasileiros de Dermatologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abd.2021.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedade Brasileira de Dermatologia.","name":"copyright","label":"Copyright"}]}}